Predicting drug approvals: The Novartis data science and artificial intelligence challenge
We describe a novel collaboration between academia and industry, an in-house data science and artificial intelligence challenge held by Novartis to develop machine-learning models for predicting drug-development outcomes, building upon research at MIT using data from Informa as the starting point. W...
Main Authors: | Siah, Kien Wei (Author), Kelley, Nicholas W (Author), Ballerstedt, Steffen (Author), Holzhauer, Björn (Author), Lyu, Tianmeng (Author), Mettler, David (Author), Sun, Sophie (Author), Wandel, Simon (Author), Zhong, Yang (Author), Zhou, Bin (Author), Pan, Shifeng (Author), Zhou, Yingyao (Author), Lo, Andrew W (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier BV,
2022-08-03T18:09:37Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
ALCON, NOVARTIS
by: Paulo E.C. Dantas
Published: (2017-11-01) -
Vadovavimo tobulinimas UAB Novartis
by: Šiaučiulytė, Donata
Published: (2008) -
Miljöklassning av byggnader : kontorshuset Novartis
by: Westling, Rickard, et al.
Published: (2009) -
Trade Marketing v mezinárodní farmaceutické společnosti Novartis
by: Balcarová, Jana
Published: (2006) -
Machine-learning models for predicting drug approvals and clinical-phase transitions
by: Siah, Kien Wei
Published: (2017)